These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 30908706)

  • 1. Treatment access is only the first step to hepatitis C elimination: experience of universal anti-viral treatment access in Australia.
    Doyle JS; Scott N; Sacks-Davis R; Pedrana AE; Thompson AJ; Hellard ME;
    Aliment Pharmacol Ther; 2019 May; 49(9):1223-1229. PubMed ID: 30908706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prescribing direct-acting antivirals to treat hepatitis C virus in a general practice setting in Australia: 'so why not do it'?
    Heard E; Massi L; Smirnov A; Selvey LA
    Intern Med J; 2020 Sep; 50(9):1053-1058. PubMed ID: 31589351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elimination of Hepatitis C Virus in Australia: Laying the Foundation.
    Dore GJ; Hajarizadeh B
    Infect Dis Clin North Am; 2018 Jun; 32(2):269-279. PubMed ID: 29778255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Australia on track to achieve WHO HCV elimination targets following rapid initial DAA treatment uptake: A modelling study.
    Kwon JA; Dore GJ; Grebely J; Hajarizadeh B; Guy R; Cunningham EB; Power C; Estes C; Razavi H; Gray RT;
    J Viral Hepat; 2019 Jan; 26(1):83-92. PubMed ID: 30267593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progress and challenges of a pioneering hepatitis C elimination program in the country of Georgia.
    Averhoff F; Shadaker S; Gamkrelidze A; Kuchuloria T; Gvinjilia L; Getia V; Sergeenko D; Butsashvili M; Tsertsvadze T; Sharvadze L; Zarkua J; Skaggs B; Nasrullah M
    J Hepatol; 2020 Apr; 72(4):680-687. PubMed ID: 31811882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of community-based hepatitis C treatment by general practitioners and nurses in Australia through remote specialist consultation.
    Haridy J; Iyngkaran G; Nicoll A; Muller K; Wilson M; Wigg A; Ramachandran J; Nelson R; Bloom S; Sasadeusz J; Watkinson S; Colman A; Altus R; Tilley E; Stewart J; Hebbard G; Liew D; Tse E
    Intern Med J; 2021 Nov; 51(11):1927-1934. PubMed ID: 32892478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Barriers and facilitators to engaging in hepatitis C management and DAA therapy among general practitioners and drug and alcohol specialists-The practitioner experience.
    Marshall AD; Grebely J; Dore GJ; Treloar C
    Drug Alcohol Depend; 2020 Jan; 206():107705. PubMed ID: 31718924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Moving Towards Hepatitis C Microelimination Among People Living With Human Immunodeficiency Virus in Australia: The CEASE Study.
    Martinello M; Yee J; Bartlett SR; Read P; Baker D; Post JJ; Finlayson R; Bloch M; Doyle J; Shaw D; Hellard M; Petoumenos K; Lin L; Marks P; Applegate T; Dore GJ; Matthews GV
    Clin Infect Dis; 2020 Sep; 71(6):1502-1510. PubMed ID: 31585005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C virus testing, liver disease assessment and treatment uptake among people who inject drugs pre- and post-universal access to direct-acting antiviral treatment in Australia: The LiveRLife study.
    Bajis S; Grebely J; Hajarizadeh B; Applegate T; Marshall AD; Ellen Harrod M; Byrne J; Bath N; Read P; Edwards M; Gorton C; Hayllar J; Cock V; Peterson S; Thomson C; Weltman M; Jefferies M; Wood W; Haber P; Ezard N; Martinello M; Maher L; Dore GJ;
    J Viral Hepat; 2020 Mar; 27(3):281-293. PubMed ID: 31698545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aiming for elimination: Outcomes of a consultation pathway supporting regional general practitioners to prescribe direct-acting antiviral therapy for hepatitis C.
    Wade AJ; McCormack A; Roder C; McDonald K; Davies M; Scott N; Wardrop M; Athan E; Hellard ME
    J Viral Hepat; 2018 Sep; 25(9):1089-1098. PubMed ID: 29660212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimated uptake of hepatitis C direct-acting antiviral treatment among individuals with HIV co-infection in Australia: a retrospective cohort study.
    Iranpour N; Dore GJ; Martinello M; Matthews GV; Grebely J; Hajarizadeh B
    Sex Health; 2020 Jun; 17(3):223-230. PubMed ID: 32223841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reaching hepatitis C virus elimination targets requires health system interventions to enhance the care cascade.
    Scott N; Doyle JS; Wilson DP; Wade A; Howell J; Pedrana A; Thompson A; Hellard ME
    Int J Drug Policy; 2017 Sep; 47():107-116. PubMed ID: 28797497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Road to Hepatitis C Virus Cure: Practical Considerations from a Health System's Perspective.
    Jonas MC; Loftus B; Horberg MA
    Infect Dis Clin North Am; 2018 Jun; 32(2):481-493. PubMed ID: 29778267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uptake of direct-acting antiviral treatment for chronic hepatitis C in Australia.
    Hajarizadeh B; Grebely J; Matthews GV; Martinello M; Dore GJ
    J Viral Hepat; 2018 Jun; 25(6):640-648. PubMed ID: 29274192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of direct-acting antiviral therapy among Aboriginal and Torres Strait Islander peoples with HCV infection in Australia: A national real-world cohort (REACH-C).
    Hudson-Buhagiar J; Carson J; Monaghan S; Collie P; Nelson R; Van Gessel H; Read P; Hanson J; Monaghan R; Matthews G; Dore GJ; Martinello M;
    J Viral Hepat; 2023 May; 30(5):386-396. PubMed ID: 36651627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A population approach to disease management: hepatitis C direct-acting antiviral use in a large health care system.
    Belperio PS; Backus LI; Ross D; Neuhauser MM; Mole LA
    J Manag Care Spec Pharm; 2014 Jun; 20(6):533-40. PubMed ID: 24856591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An educate, test and treat model towards elimination of hepatitis C infection in Egypt: Feasibility and effectiveness in 73 villages.
    Shiha G; Soliman R; Mikhail NNH; Easterbrook P
    J Hepatol; 2020 Apr; 72(4):658-669. PubMed ID: 31734097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The epidemiology of hepatitis C in Australia: notifications, treatment uptake and liver transplantations, 1997-2006.
    Gidding HF; Topp L; Middleton M; Robinson K; Hellard M; McCaughan G; Maher L; Kaldor JM; Dore GJ; Law MG
    J Gastroenterol Hepatol; 2009 Oct; 24(10):1648-54. PubMed ID: 19798783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C care cascade before and during the direct-acting antiviral eras in New South Wales, Australia: A population-based linkage study.
    Yousafzai MT; Alavi M; Valerio H; Hajarizadeh B; Grebely J; Dore GJ
    J Viral Hepat; 2023 Mar; 30(3):250-261. PubMed ID: 36537024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The case for a universal hepatitis C vaccine to achieve hepatitis C elimination.
    Scott N; Wilson DP; Thompson AJ; Barnes E; El-Sayed M; Benzaken AS; Drummer HE; Hellard ME
    BMC Med; 2019 Sep; 17(1):175. PubMed ID: 31530275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.